Table 2.

The effect of the intervention on FP use and pregnancy at second-year follow-up

Model	Unadjusted	Adjusted
Panel A: Current use of FP
Treatment	0.057**	0.059**
	[0.022, 0.092]	[0.024, 0.094]
Panel B: Long-acting method use
Treatment	0.055**	0.054**
	[0.020, 0.090]	[0.020, 0.089]
Panel C: Injectable use
Treatment	–0.0066	0.00088
	[–0.046,0.033]	[–0.039,0.040]
Panel D: Implant use
Treatment	0.040**	0.043**
	[0.0070, 0.074]	[0.011, 0.075]
Observations	1,672	1,667
Panel E: Pregnant again since index birth
Treatment	–0.038**	–0.037**
	[–0.0618,–0.0137]	[–0.0621,–0.0111]
Observations	1,581	1,475

Each observation is a woman. The results presented are from intent-to-treat linear probability models, and 95% CIs, which are calculated with heteroskedasticity-robust SEs, are presented in brackets. The adjusted regressions, reported in column 2, include the following covariates at baseline: the woman’s total number of children who are alive, her educational attainment (primary or less versus secondary and higher), her age (in three age groups), age of sexual debut, ever use of FP her religion, work status, and tribal group. The adjusted regressions also include neighborhood fixed effects and control for baseline levels of the outcome. For Panel E, the time since the index birth (in months) is included as an additional control variable.

**P < 0.05.